{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T07:23:32Z","timestamp":1700637812922},"reference-count":35,"publisher":"Europa Digital & Publishing","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.4244\/eijv4i5a98","type":"journal-article","created":{"date-parts":[[2010,8,24]],"date-time":"2010-08-24T14:02:11Z","timestamp":1282658531000},"page":"578-587","source":"Crossref","is-referenced-by-count":7,"title":["Interventional treatment in diabetics in the era of drug-eluting stents and compliance to the ESC guidelines: lessons learned from the Euro Heart Survey Programme"],"prefix":"10.4244","volume":"4","author":[{"given":"Yoshinobu","family":"Onuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neville","family":"Kukreja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Ramcharitar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Hochadel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anselm","family":"Gitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Serruys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2774","reference":[{"key":"key-2010816191234-0","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/01.CIR.94.8.1818","article-title":"Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.","volume":"94","author":"Kip KE","year":"1996","journal-title":"Circulation"},{"key":"key-2010816191234-1","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/S0735-1097(00)01205-5","article-title":"Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group.","volume":"37","author":"Niles NW","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"key-2010816191234-2","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S0003-4975(99)00143-5","article-title":"Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting.","volume":"67","author":"Thourani VH","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"key-2010816191234-3","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/01.CIR.0000116750.63158.94","article-title":"Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients.","volume":"109","author":"West NE","year":"2004","journal-title":"Circulation"},{"key":"key-2010816191234-4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0195-668X(02)00618-8","article-title":"Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.","volume":"24","author":"Van de Werf F","year":"2003","journal-title":"Eur Heart J"},{"key":"key-2010816191234-5","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/S0002-9149(02)02770-4","article-title":"Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry).","volume":"90","author":"Laskey WK","year":"2002","journal-title":"Am J Cardiol"},{"key":"key-2010816191234-6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s001250050032","article-title":"The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register follow-up study.","volume":"43","author":"Lowel H","year":"2000","journal-title":"Diabetologia"},{"key":"key-2010816191234-7","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/01.CIR.102.9.1014","article-title":"Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry.","volume":"102","author":"Malmberg K","year":"2000","journal-title":"Circulation"},{"key":"key-2010816191234-8","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1053\/euhj.2000.2317","article-title":"Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators.","volume":"21","author":"McGuire DK","year":"2000","journal-title":"Eur Heart J"},{"key":"key-2010816191234-9","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.2337\/diacare.24.8.1422","article-title":"Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction.","volume":"24","author":"Mukamal KJ","year":"2001","journal-title":"Diabetes Care"},{"key":"key-2010816191234-10","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.2337\/diacare.26.10.2770","article-title":"Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes.","volume":"26","author":"Tenerz A","year":"2003","journal-title":"Diabetes Care"},{"key":"key-2010816191234-11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jacc.2003.08.050","article-title":"Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.","volume":"43","author":"Norhammar A","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"key-2010816191234-12","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/eurheartj\/ehi238","article-title":"Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.","volume":"26","author":"Lenzen MJ","year":"2005","journal-title":"Eur Heart J"},{"key":"key-2010816191234-13","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/eurheartj\/ehi774","article-title":"Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey.","volume":"27","author":"Rosengren A","year":"2006","journal-title":"Eur Heart J"},{"key":"key-2010816191234-14","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/eurheartj\/ehi138","article-title":"Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.","volume":"26","author":"Silber S","year":"2005","journal-title":"Eur Heart J"},{"key":"key-2010816191234-15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/eurheartj\/ehi079","article-title":"The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice.","volume":"26","author":"Flynn MR","year":"2005","journal-title":"Eur Heart J"},{"key":"key-2010816191234-16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0195-668X(02)00618-8","article-title":"Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.","volume":"24","author":"Van de Werf F","year":"2003","journal-title":"Eur Heart J"},{"key":"key-2010816191234-17","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00125-004-1438-z","article-title":"Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys.","volume":"47","author":"Pyorala K","year":"2004","journal-title":"Diabetologia"},{"key":"key-2010816191234-18","first-page":"S1","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).","volume":"10","author":"De Backer G","year":"2003","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"key-2010816191234-19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1136\/bmj.326.7380.84","article-title":"Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care.","volume":"326","author":"Murchie P","year":"2003","journal-title":"Bmj"},{"key":"key-2010816191234-20","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1136\/bmj.323.7319.957","article-title":"Randomised trials of secondary prevention programmes in coronary heart disease: systematic review.","volume":"323","author":"McAlister FA","year":"2001","journal-title":"Bmj"},{"key":"key-2010816191234-21","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.amjcard.2006.12.039","article-title":"Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry).","volume":"99","author":"Steinberg BA","year":"2007","journal-title":"Am J Cardiol"},{"key":"key-2010816191234-22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ahj.2005.02.038","article-title":"Long-term adherence with cardiovascular drug regimens.","volume":"151","author":"Kulkarni SP","year":"2006","journal-title":"Am Heart J"},{"key":"key-2010816191234-23","first-page":"88","article-title":"Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).","volume":"28","author":"Ryden L","year":"2007","journal-title":"Eur Heart J"},{"key":"key-2010816191234-24","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0002-9149(03)00145-0","article-title":"Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction.","volume":"91","author":"Harjai KJ","year":"2003","journal-title":"Am J Cardiol"},{"key":"key-2010816191234-25","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.jacc.2007.05.049","article-title":"Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.","volume":"50","author":"Angiolillo DJ","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"key-2010816191234-26","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.amjcard.2005.10.064","article-title":"Clopidogrel loading dose (300 versus 600 mg) strategies for patients with stable angina pectoris subjected to percutaneous coronary intervention.","volume":"97","author":"Wolfram RM","year":"2006","journal-title":"Am J Cardiol"},{"key":"key-2010816191234-27","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1161\/CIRCULATIONAHA.107.740324","article-title":"Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.","volume":"116","author":"Wiviott SD","year":"2007","journal-title":"Circulation"},{"key":"key-2010816191234-28","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes.","volume":"357","author":"Wiviott SD","year":"2007","journal-title":"N Engl J Med"},{"key":"key-2010816191234-29","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.ahj.2006.04.012","article-title":"Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).","volume":"152","author":"Wiviott SD","year":"2006","journal-title":"Am Heart J"},{"key":"key-2010816191234-30","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1161\/CIRCULATIONAHA.107.752147","article-title":"Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.","volume":"118","author":"Daemen J","year":"2008","journal-title":"Circulation"},{"key":"key-2010816191234-31","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.","volume":"370","author":"Stettler C","year":"2007","journal-title":"Lancet"},{"key":"key-2010816191234-32","first-page":"1393","article-title":"Effectiveness and safety of drug-eluting stents in Ontario.","volume":"357","author":"Tu JV","journal-title":"N Engl J Med."},{"key":"key-2010816191234-33","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4244\/EIJV3I3A71","article-title":"Prognostic impact of major bleeding in patients with acute coronary syndromes. A systematic review and meta-analysis.","volume":"3","author":"Hamon M","year":"2007","journal-title":"EuroIntervention"},{"key":"key-2010816191234-34","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.amjcard.2006.02.039","article-title":"Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up.","volume":"98","author":"Park DW","year":"2006","journal-title":"Am J Cardiol."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T09:03:46Z","timestamp":1497863026000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/18th_issue\/98"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["EIJV4I5A98"],"URL":"https:\/\/doi.org\/10.4244\/eijv4i5a98","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}